TOMITA Kyouichi 冨田京一

… Alternative Names

KYOICHI Tomita 富田京一

TOMETA Kyoichi 冨田京一

TOMITA Kyoichi 富田京一

Less

Researcher Number	20272578
Affiliation (based on the past Project Information) *help	2007 – 2008: The University of Tokyo, 医学部・附属病院, 准教授 2007: 東京大学, 医学部附属病院, 准教授 2007: The University of Tokyo, Hospital, associate professor 2005 – 2006: The University of Tokyo, Faculty of Medicine, Associate professor, 医学部附属病院, 助教授 2002 – 2004: the University of Tokyo, Faculty of Medicine, Lecturer, The University of Tokyo Faculty of Medicine, Lecturer 2001: 東京大学, 医学部・附属病院, 講師 1996 – 1997: 東京大学, 医学部・附属病院, 助手
Review Section/Research Field	Principal Investigator Urology / Urology Except Principal Investigator Urology / Urology
Keywords	Principal Investigator N-cadherin / cadherin switching / E-cadherin / invasion / 浸潤 / Th2 / IL4 / confocal scanning laser microscopy / prognosis / bladder cancer … More / HGF / 培養細胞 / c-Met / 共焦点レーザー顕微鏡 / 予後 / 膀胱癌 / metastais / cadherin-11 / prostate cancer / カドヘリン-11 / 転移 / カドヘリンー11 / N-カドヘリン / 前立腺癌 / Transplantation / IL-4 / トランスジェニック / Th1 / 移植 / 金属酵素阻害剤 / 浸潤・転移 / 腎細胞癌 … More Except Principal Investigator ras / TNF / Catechol-O-methyltransferase / 17β-hydroxysteroid dehydrogenase / Cytochrome P450 1A1 / Tailor-made medication / Prostate cancer / Estramustine phosphate sodium / Single nucleotide polymorphism / 膀胱癌 / 前立腺癌 / inflammation / bladder cancer / Ras / mast cell / 肥満細胞 / 炎症 / 2-methoxyestradiol / Estramustine phoshate sodium / Cytochrome P450 / カトクロームP450 1A1 / カテコールOメチル基転移酵素 / 17ベータ水酸化ステロイド脱水素酵素 / テーラーメイド医療 / リン酸エストラムスチン / 一塩基多型 / α1D-knockout mice / volume analysis / frequency / overactive bladder / α1D-adrenoceptor / 24時間尿道モニター / 尿道狭窄マウス / 膀胱α1d受容体 / α1D-KOマウス / 下部尿路通過障害 / 膀胱α-1アドレナリン受容体 / α1D-ノックアウトマウス / 48時間排尿動態 / 過活動膀胱 / α1-アドレナリン受容体 / cytokine / intravesical BCG instillation / animal model / human bladder cancer / 免疫療法 / BCG / サイトカイン / 動物モデル / BCG膀胱内注入 / 癌 / 遺伝子治療 / ウイルス療法 Less

Construction of oncolytic virus therapy to show an anti-tumor effect selectively against prostate cancer
- Principal Investigator
  
  FUKUHARA Hiroshi
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo
N-cadherin expression is associated with bladder cancer progression and poor prognosisPrincipal Investigator
- Principal Investigator
  
  TOMITA Kyoichi
- Project Period (FY)
  2005 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo
Clinical trial of the tailor-made medication for the treatment of prostate cancer by estramustine phosphate sodium.
- Principal Investigator
  
  KITAMURA Tadaichi
- Project Period (FY)
  2003 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo
The involvement of mast cell in the progression of bladder cancer
- Principal Investigator
  
  MUTO Satoru
- Project Period (FY)
  2003 – 2005
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Teikyo University
The role of α1-adrenoceptor subtypes on the bladder function associated with bladder outlet obstruction : Function of the lower urinary tract in α1D-adrenoceptor knockout mice
- Principal Investigator
  
  OHTA Nobutaka
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo
The correlation between expression of N-cadherin and cadherin-11, and both cancer invasion and metastasis in prostate cancerPrincipal Investigator
- Principal Investigator
  
  KYOICHI Tomita
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo
金属酵素阻害剤による腎細胞癌の浸潤・転移抑制の研究Principal Investigator
- Principal Investigator
  
  冨田京一
- Project Period (FY)
  1996
- Research Category
  
  Grant-in-Aid for Encouragement of Young Scientists (A)
- Research Field
  
  Urology
- Research Institution
  The University of Tokyo
RESEARCH of the intravesical immunotherapy for human bladder cancer
- Principal Investigator
  
  KAMEYAMA Shuji
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  University of Tokyo
Murine IL-4 Transgenic Heart Allograft Survival Prolonged With Downregulation of Th1 Cytokine mRNA in Grafts.Principal Investigator
- Principal Investigator
  
  TOMITA Kyoichi, 武内巧
- Project Period (FY)
  1996 – 1997
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  University of Tokyo

All 2006 2005 2003 2002

All Journal Article Presentation

[Journal Article] Single Nucleotide Polymorphisms in the 17beta-hydroxysteroid Dehydrogenase Genes May Predict the Risk of Side Effects of Estramustine Phosphate Sodium in Prostate Cancer Patients2005
- Author(s)
  Suzuki M, Muto S, Hara K, Ozeki T, Yamada Y, Kadowaki T, Tomita K, Kameyama S, Kitamura T.
- Journal Title
  
  Int J Urol 12
  
  Pages: 166-172
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] Single Nucleotide Polymorphisms in the 17beta-hydroxysteroid Dehydrogenase Genes May Predict the Risk of Side Effects of Estramustine Phosphate Sodium in Prostate Cancer Patients2005
- Author(s)
  Suzuki M, Muto S, Hara K, Ozeki T, Yamada Y, Kadowaki T, Tomita K, Kameyama S, Kitamura T
- Journal Title
  
  Int J Urol 12
  
  Pages: 166-172
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] Dual interim report of low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer2005
- Author(s)
  Kitamura T, Nishimatsu H, Suzuki M, Mohammed R, Tomita K, Takahashi S, Takeuchi T, Ohota N, Kameyama S
- Journal Title
  
  J Appl Res 5(2)
  
  Pages: 331-344
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] Single Nucleotide Polymorphisms in the 17 β-hydroxysteroid Dehydrogenase Genes May Predict the Risk of Side Effects of Estramustine Phosphate Sodium in Prostate Cancer Patients2005
- Author(s)
  Suzuki M, Muto S, Hara K, Ozeki T, Yamada Y, Kadowaki T, Tomita K, Kameyama S, Kitamura T
- Journal Title
  
  International Journal of Urology 12・2
  
  Pages: 166-172
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] Dual interim report of low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer2005
- Author(s)
  Kitamura T, Nishimatsu H, Suzuki M, Mohammed R, Tomita K, Takahashi S, Takeuchi T, Ohota N, Kameyama S
- Journal Title
  
  J Appl Res 5 (2)
  
  Pages: 331-344
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] Dual interim report of low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer2005
- Author(s)
  Kitamura T, Nishimatsu H, Suzuki M, Mohammed R, Tomita K, Takahashi S, Takeuchi T, Ohota N, Kameyama S
- Journal Title
  
  j Appl Res 5・2
  
  Pages: 331-344
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] 前立腺癌に対するエストラサイト療法における副作用発症の個体差について2003
- Author(s)
  鈴木基文, 武藤智, 西松寛明, 冨田京一, 太田信隆, 北村唯一
- Journal Title
  
  日本腎泌尿器疾患予防医学研究会誌 12・1
  
  Pages: 63-64
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] Interindividual difference of adverse effects during estramustine phosphate therapy for prostate cancer2003
- Author(s)
  Suzuki M, Muto S, Nishimatsu H, Tomita K, Ohta N, Kitamura T.
- Journal Title
  
  Prev Nephrol Urol 12 (1)
  
  Pages: 63-64
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] EMP combination chemotherapy and low-dose monotherapy in advanced prostate cancer2002
- Author(s)
  Kitamura T, Nishimatsu H, Hamamoto T, Tomita K, Takeuchi T, Ohta N
- Journal Title
  
  Expert Rev Anticancer Ther 2
  
  Pages: 59-71
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Journal Article] EMP combination chemotherapy and low-dose monotherapy in advanced prostate cancer2002
- Author(s)
  Kitamura T, Nishimatsu H, Hamamoto T, Tomita K, Takeuchi T, Ohta N.
- Journal Title
  
  Expert Rev Anticancer Ther 2
  
  Pages: 59-71
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-15390485
[Presentation] N-cadherin expression is associated with blabber cancer progression and poor prognosis2006
- Author(s)
  Kyoichi Tomita
- Organizer
  21th congress of European association of Urology
- Place of Presentation
  Istanbul
- Year and Date
  2006-03-18
- Description
  「研究成果報告書概要(和文)」より
- Data Source
  KAKENHI-PROJECT-17591664
[Presentation] N-cadherin expression is associated with blabber cancer progression and poor prognosis.2006
- Author(s)
  Tomita K, Kume H, Kashibuchi K, Kitamura T.
- Organizer
  21th congress of European association of Urology
- Place of Presentation
  Istanbul
- Year and Date
  2006-03-18
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591664

1. KITAMURA Tadaichi (70010551)

# of Collaborated Projects: 4 results

# of Collaborated Products: 11 results
2. ARUGA Seiji (90322057)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
3. TAKEUCHI Takumi (90167487)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. OHTA Nobutaka (50160510)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
5. HORIE Shigeo (40190243)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
6. KUME Haruki (10272577)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
7. FUKUHARA Hiroshi (20292948)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. TOUDOU Tomoki (80272566)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. FUJIMURA Tetsuya (50376448)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. KAMEYAMA Shuji (90186015)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. TAKAHASHI Satoru (50197141)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. NISHIMATSU Hiroaki (60251295)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
13. MUTO Satoru (30345194)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 堀江重郎 (40201660)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 鈴木基文 (50401063)

# of Collaborated Projects: 1 results

# of Collaborated Products: 8 results
16. 山田雄太 (10376452)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. TSUJIMOTO Gozoh

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
18. SHINOURA Hitomi

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

TOMITA Kyouichi 冨田 京一

KYOICHI Tomita 富田 京一

TOMETA Kyoichi 冨田 京一

TOMITA Kyoichi 富田 京一

Research Projects

Research Products

Co-Researchers

Construction of oncolytic virus therapy to show an anti-tumor effect selectively against prostate cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

N-cadherin expression is associated with bladder cancer progression and poor prognosisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical trial of the tailor-made medication for the treatment of prostate cancer by estramustine phosphate sodium.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The involvement of mast cell in the progression of bladder cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of α1-adrenoceptor subtypes on the bladder function associated with bladder outlet obstruction : Function of the lower urinary tract in α1D-adrenoceptor knockout mice

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The correlation between expression of N-cadherin and cadherin-11, and both cancer invasion and metastasis in prostate cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

金属酵素阻害剤による腎細胞癌の浸潤・転移抑制の研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

RESEARCH of the intravesical immunotherapy for human bladder cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Murine IL-4 Transgenic Heart Allograft Survival Prolonged With Downregulation of Th1 Cytokine mRNA in Grafts.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Single Nucleotide Polymorphisms in the 17beta-hydroxysteroid Dehydrogenase Genes May Predict the Risk of Side Effects of Estramustine Phosphate Sodium in Prostate Cancer Patients2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Single Nucleotide Polymorphisms in the 17beta-hydroxysteroid Dehydrogenase Genes May Predict the Risk of Side Effects of Estramustine Phosphate Sodium in Prostate Cancer Patients2005

Author(s)

Journal Title

Description

Data Source

[Journal Article] Dual interim report of low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer2005

Author(s)

Journal Title

Data Source

[Journal Article] Single Nucleotide Polymorphisms in the 17 β-hydroxysteroid Dehydrogenase Genes May Predict the Risk of Side Effects of Estramustine Phosphate Sodium in Prostate Cancer Patients2005

Author(s)

Journal Title

Data Source

[Journal Article] Dual interim report of low-dose estramustine phosphate (EMP) monotherapy and very low-dose EMP therapy combined with LH-RH agonist for previously untreated advanced prostate cancer2005

TOMITA Kyouichi 冨田京一

KYOICHI Tomita 富田京一

TOMETA Kyoichi 冨田京一

TOMITA Kyoichi 富田京一